Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Roberta Manti
Observed names:
R Manti,
R. Manti
Institution:
Regione Piemonte
Observed institutions:
Regione Piemonte,
University of Turin
ORCID:
0009-0005-3443-8603
Observed ORCID:
0009-0005-3443-8603
OpenAlex ID:
A5001050579
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
2022
·
Peter Rossing
, Stefan D. Anker
, et al.
·
Diabetes Care
·
238
PDF
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2023
·
Rajiv Agarwal
, Wanzhu Tu
, et al.
·
Annals of Internal Medicine
·
121
Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats.
2000
·
M Aragno
, S Parola
, et al.
·
Diabetes
·
119
PDF
The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes
2016
·
Gabriele Forlani
, Carlo Giorda
, et al.
·
Journal of Diabetes Research
·
106
PDF
35th Annual Meeting of the European Association for the Study of Diabetes
1999
·
A. Melander
, J. Olsson
, et al.
·
Diabetologia
·
87
Oxidative derangement in rat synaptosomes induced by hyperglycaemia: restorative effect of dehydroepiandrosterone treatment
2000
·
Manuela Aragno
, Silvia Parola
, et al.
·
Biochemical Pharmacology
·
85
Dehydroepiandrosterone Modulates Nuclear Factor-κB Activation in Hippocampus of Diabetic Rats
2002
·
Manuela Aragno
, Raffaella Mastrocola
, et al.
·
Endocrinology
·
84
Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients
2007
·
Nicoletta Fortunati
, Roberta Manti
, et al.
·
Oncology Reports
·
61
PDF
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
2022
·
Peter Rossing
, Ellen Burgess
, et al.
·
Diabetes Care
·
41
PDF
Protective effect of dehydroepiandrosterone against lipid peroxidation in a human liver cell line
1999
·
M Gallo
, M Aragno
, et al.
·
European Journal of Endocrinology
·
36
Oxidative stress and eicosanoids in the kidneys of hyperglycemic rats treated with dehydroepiandrosterone
2001
·
Manuela Aragno
, Silvia Parola
, et al.
·
Free Radical Biology and Medicine
·
31
Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients
2017
·
Carlo Bruno Giorda
, Gabriele Forlani
, et al.
·
Diabetes Research and Clinical Practice
·
29
Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes
2016
·
Carlo Giorda
, Gabriele Forlani
, et al.
·
Diabetes/Metabolism Research and Reviews
·
29
Ectopic secretion of LH by an endocrine pancreatic tumor
2004
·
E. Brignardello
, R. Manti
, et al.
·
Journal of Endocrinological Investigation
·
22
Dehydroepiandrosterone prevents lipid peroxidation and cell growth inhibition induced by high glucose concentration in cultured rat mesangial cells
2000
·
E Brignardello
, M Gallo
, et al.
·
Journal of Endocrinology
·
19
PDF
Hepatocellular carcinoma in a large cohort of type 2 diabetes patients
2023
·
Carlo B. Giorda
, Roberta Picariello
, et al.
·
Diabetes Research and Clinical Practice
·
15
Feasibility and accuracy of the screening for diabetic retinopathy using a fundus camera and an artificial intelligence pre-evaluation application
2023
·
A. Piatti
, F. Romeo
, et al.
·
Acta Diabetologica
·
12
Increased incidence of type 1 diabetes in 2 years of COVID-19 pandemic
2022
·
Carlo Bruno Giorda
, Roberto Gnavi
, et al.
·
Acta Diabetologica
·
11
PDF
Diabetic retinopathy screening with confocal fundus camera and artificial intelligence - assisted grading
2024
·
A. Piatti
, C. Rui
, et al.
·
European Journal of Ophthalmology
·
10
PIONEER REAL Italy: Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 Diabetes
2025
·
Roberta Manti
, Salvatore De Cosmo
, et al.
·
Diabetes Therapy
·
7
Identification of the Inappropriate Clinical Actions (DON'T) to Improve the Management of Patients with Type 2 Diabetes Failing Basal Insulin Supported Oral Treatment: Results of Survey for a Panel of Diabetes Specialists in Italy
2021
·
Gaetano Leto
, Ilaria Barchetta
, et al.
·
Diabetes Therapy
·
4
PDF
Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897
2023
·
Peter Rossing
, Ellen Burgess
, et al.
·
Diabetes Care
·
1
PDF
Correction to: Increased incidence of type 1 diabetes in 2 years of COVID‑19 pandemic
2023
·
Carlo Bruno Giorda
, Roberto Gnavi
, et al.
·
Acta Diabetologica
PDF
Un Approccio Clinico Sostenibile alla Gestione delle Epatopatie nel Diabete Mellito
2016
·
Roberta Manti
·
MEDIA - Aggiornamento e formazione in diabetologia e malattie metaboliche
La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale [Subcutaneous insulin infusion (CSII) in italy: The third national survey]
2015
·
Daniela Bruttomesso
, Luigi Laviola
, et al.
·
IRIS UNIMORE (University of Modena and Reggio Emilia)
Show more works
View as search
Works count:
28
Citation count:
1,168
H-index:
15
I10-index:
19
Year
Topic
Type